Evidence map›Paper›PMID 41375036›Full record

ArticleCancers2025

Deriving Real-World Evidence from Non-English Electronic Medical Records in Hormone Receptor-Positive Breast Cancer Using Large Language Models.

Daur Meretukov, Katerina Grechukhina, Vladimir Evdokimov, Dmitry Didych, Sofia Kondratieva, Olga Rakitina, Alexander Gordeev, Polina Shilo, Igor Khatkov, Lyudmila Zhukova

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Daur MeretukovDepartment of Science, N.N. Blokhin Cancer Research Center, Moscow 115478, Russia.
Katerina GrechukhinaSBIH Moscow Clinical Scientific Center Named After A.S. Loginov of DHM, Moscow 111123, Russia.
Vladimir EvdokimovSBIH Moscow Multidisciplinary Clinical Center "Kommunarka" of DHM, Moscow 117638, Russia.ORCID 0000-0002-0591-7921
Dmitry DidychGroup of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow 117997, Russia.
Sofia KondratievaGroup of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow 117997, Russia.ORCID 0000-0002-1354-5275
Olga RakitinaGroup of Gene Immuno-Oncotherapy, Department of Genomics and Postgenomic Technologies, Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences, Moscow 117997, Russia.ORCID 0000-0003-4485-0405
Alexander GordeevLLC "Technology of Trust", Moscow 125167, Russia.ORCID 0009-0006-6003-8934
Polina ShiloLahta Clinic Medical Center, St. Petersburg 197183, Russia.
Igor KhatkovSBIH Moscow Clinical Scientific Center Named After A.S. Loginov of DHM, Moscow 111123, Russia.
Lyudmila ZhukovaSBIH Moscow Clinical Scientific Center Named After A.S. Loginov of DHM, Moscow 111123, Russia.ORCID 0000-0003-4848-6938

Funding

Moscow Government 0903-2
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AIartificial intelligenceBCbreast cancerlarge language modelLLMLPP“luminal B poor-prognosis” breast cancerreal-world dataRWD

Identifiers

PMID41375036
PMCPMC12691197

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.